Applications Published 6 June 2001
Published: 8-Mar-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Transdermally delivered aspirin
Galat, Alexander 1104236*Aqueous preservative
Norsk Hydro 1104237*Suspension concentrate formulation containing pyrimethanil
Aventis Formulation 1104238*Use of stable concentrated water-in-oil emulsions for controlled transcutaneous release of an active principle
Laboratoires de Biologie Vegetale Rocher 1104279*Topical delivery system for active agents
Johnson & Johnson Consumer Companies 1104280*Incorporation of exogenous lactic acid into the moral microflora
Societe des Produits Nestle 1104281*Enhanced antiperspirant salts stabilised with calcium and concentrated aqueous solutions of such salts
The Gillette Company 1104282*Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
Sol-Gel Technologies 1104287*Orally disintegrable tablet forming a viscous slurry
Cima Labs 1104288*New oral formulation for 5-HT4 agonists or antagonists
Novartis 1104289*Microemulsions as solid dosage forms for oral administration
Cima Labs 1104290*Treatment of vasodilatory headache
Vernalis 1104292*Regulation of substrate activity
Achkar, Charles 1104294*Use of quaternary nitrogen compounds for prophylaxis or treatment of superinfected atopic eczema
Beiersdorf Aktiengesellschaft 1104295*Bioimplant formulation
Pepetech 1104296*Methods and compsns for the treatment of chronic lymphocytic leukaemia
Nardella, Francis; Sitzer, Ruth 1104297*Hetercyclic thioesters or ketones for vision and memory disorders
GPI NIL Holdings 1104298*N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
GPI NIL HoldingsCarboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
GPI NIL Holdings 1104300*Method of treatment
SmithKline Beecham 1104301*Prophylactic treatment of neovascularisation in macular degeneration
The University of Sydney 1104302*Carbohydrate or 2'-modified oligonucleotides having alternating internulceoside linkages
Isis Pharmaceuticals 1104303*Multivalent AVB3 and metastasis-associated receptor ligands
GD Searle 1104304*Cancer treatment
Queen Mary and Westfield College 1104305*Compositions of CPG and saponin adjuvants and methods thereof
Aquila Biopharmaceuticals 1104306*Pharmaceutical compsn having inhibitory effect on overproduction and accumulation of extracellular matrix
Teijin Ltd 1104307*Antibodies for use in targeted and temporary treatment of humans and animals Wouters, Stanislaus Laurens Johan; Renggli, Heinz Helmut; Horbach, Danielle
Angelique 1104308*Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
Valentis 1104309*Stabilised compsns having anti-bacterial activity
Coloplast 1104311*
